First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

计划入组 276 人 · 首次发布于 2022 年 8 月 5 日

Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer

计划入组 6 人 · 首次发布于 2016 年 6 月 10 日

Association of β-amyloid 40 and 42 With Prediabetes

计划入组 1,442 人 · 首次发布于 2021 年 9 月 5 日

HLX-42

ASC-42

K-42

Level 42 AI, Inc.

United States

ASSOCIACAO DE FORMANDOS DA 42 TURMA DA FACULDADE DE MEDICINA DO ABC-COMFOR XLII

Brazil

Johnson & Johnson

United States

AI Searches 100 Million Possibilities to Democratize 3D Printing of NASA's GRCop-42 Alloy

Hilo Secures $42 Million Series B Funding to Revolutionize Blood Pressure Monitoring

BridgeBio's Attruby (acoramidis) Approved by FDA for ATTR-CM Treatment